Global Powder for Inhalation Market Growth 2026-2032
The global Powder for Inhalation market size is predicted to grow from US$ 13900 million in 2025 to US$ 19170 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
Powder for inhalation (used in dry powder inhalers, DPIs) delivers active pharmaceutical ingredients as respirable powders driven by patient inhalation and is widely used for local treatment of respiratory diseases (asthma, COPD) and selected systemic applications (e.g., inhaled insulin). Key technical challenges are particle-size distribution, powder flow/dispersibility, physical stability and device–formulation compatibility (capsule-based, blister, or multi-dose devices); common manufacturing technologies include spray-drying, spray-freeze-drying and particle-engineering approaches to achieve the required aerosol performance. Upstream inputs include inhalation-grade APIs (with tight impurity/residual-solvent specs) and lung-safe excipients — lactose remains the predominant carrier in many commercial formulations — and many projects outsource formulation development and scale-up to specialized CDMOs.
In 2024, the global market average price for Powder for Inhalation was USD 26.7 per unit, with a total sales volume of 512 million units.
United States market for Powder for Inhalation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Powder for Inhalation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Powder for Inhalation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Powder for Inhalation players cover GSK, Novartis, AstraZeneca, Chiesi Farmaceutici, Teva Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Powder for Inhalation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Powder for Inhalation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Powder for Inhalation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Powder for Inhalation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Powder for Inhalation.
This report presents a comprehensive overview, market shares, and growth opportunities of Powder for Inhalation market by product type, application, key manufacturers and key regions and countries.
Powder for inhalation (used in dry powder inhalers, DPIs) delivers active pharmaceutical ingredients as respirable powders driven by patient inhalation and is widely used for local treatment of respiratory diseases (asthma, COPD) and selected systemic applications (e.g., inhaled insulin). Key technical challenges are particle-size distribution, powder flow/dispersibility, physical stability and device–formulation compatibility (capsule-based, blister, or multi-dose devices); common manufacturing technologies include spray-drying, spray-freeze-drying and particle-engineering approaches to achieve the required aerosol performance. Upstream inputs include inhalation-grade APIs (with tight impurity/residual-solvent specs) and lung-safe excipients — lactose remains the predominant carrier in many commercial formulations — and many projects outsource formulation development and scale-up to specialized CDMOs.
In 2024, the global market average price for Powder for Inhalation was USD 26.7 per unit, with a total sales volume of 512 million units.
United States market for Powder for Inhalation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Powder for Inhalation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Powder for Inhalation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Powder for Inhalation players cover GSK, Novartis, AstraZeneca, Chiesi Farmaceutici, Teva Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Powder for Inhalation Industry Forecast” looks at past sales and reviews total world Powder for Inhalation sales in 2025, providing a comprehensive analysis by region and market sector of projected Powder for Inhalation sales for 2026 through 2032. With Powder for Inhalation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Powder for Inhalation industry.This Insight Report provides a comprehensive analysis of the global Powder for Inhalation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Powder for Inhalation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Powder for Inhalation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Powder for Inhalation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Powder for Inhalation.
This report presents a comprehensive overview, market shares, and growth opportunities of Powder for Inhalation market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Tiotropium Bromide
- Salbutamol Sulfate
- Beclomethasone Dipropionate
- Others
Segmentation by Application:
- Asthma
- COPD
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Novartis
- AstraZeneca
- Chiesi Farmaceutici
- Teva Pharmaceutical
- Sumitomo Pharma
- Cipla
- Glenmark Pharmaceuticals
- Orion Corporation
- Bausch Health
- Viatris
- Zhejiang Xianjun Pharmaceutical
- Shanghai Pharmaceuticals
- Chia Tai Tianqing Pharmaceutical
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Powder for Inhalation market?
- What factors are driving Powder for Inhalation market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Powder for Inhalation market opportunities vary by end market size?
- How does Powder for Inhalation break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Powder for Inhalation Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Powder for Inhalation by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Powder for Inhalation by Country/Region, 2021, 2025 & 2032
2.2 Powder for Inhalation Segment by Type
2.2.1 Tiotropium Bromide
2.2.2 Salbutamol Sulfate
2.2.3 Beclomethasone Dipropionate
2.2.4 Others
2.2.5 Powder for Inhalation Sales by Type
2.2.5.1 Global Powder for Inhalation Sales Market Share by Type (2021-2026)
2.2.5.2 Global Powder for Inhalation Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Powder for Inhalation Sale Price by Type (2021-2026)
2.3 Powder for Inhalation Segment by Application
2.3.1 Asthma
2.3.2 COPD
2.3.3 Others
2.3.4 Powder for Inhalation Sales by Application
2.3.4.1 Global Powder for Inhalation Sale Market Share by Application (2021-2026)
2.3.4.2 Global Powder for Inhalation Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Powder for Inhalation Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Powder for Inhalation Breakdown Data by Company
3.1.1 Global Powder for Inhalation Annual Sales by Company (2021-2026)
3.1.2 Global Powder for Inhalation Sales Market Share by Company (2021-2026)
3.2 Global Powder for Inhalation Annual Revenue by Company (2021-2026)
3.2.1 Global Powder for Inhalation Revenue by Company (2021-2026)
3.2.2 Global Powder for Inhalation Revenue Market Share by Company (2021-2026)
3.3 Global Powder for Inhalation Sale Price by Company
3.4 Key Manufacturers Powder for Inhalation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Powder for Inhalation Product Location Distribution
3.4.2 Players Powder for Inhalation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POWDER FOR INHALATION BY GEOGRAPHIC REGION
4.1 World Historic Powder for Inhalation Market Size by Geographic Region (2021-2026)
4.1.1 Global Powder for Inhalation Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Powder for Inhalation Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Powder for Inhalation Market Size by Country/Region (2021-2026)
4.2.1 Global Powder for Inhalation Annual Sales by Country/Region (2021-2026)
4.2.2 Global Powder for Inhalation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Powder for Inhalation Sales Growth
4.4 APAC Powder for Inhalation Sales Growth
4.5 Europe Powder for Inhalation Sales Growth
4.6 Middle East & Africa Powder for Inhalation Sales Growth
5 AMERICAS
5.1 Americas Powder for Inhalation Sales by Country
5.1.1 Americas Powder for Inhalation Sales by Country (2021-2026)
5.1.2 Americas Powder for Inhalation Revenue by Country (2021-2026)
5.2 Americas Powder for Inhalation Sales by Type (2021-2026)
5.3 Americas Powder for Inhalation Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Powder for Inhalation Sales by Region
6.1.1 APAC Powder for Inhalation Sales by Region (2021-2026)
6.1.2 APAC Powder for Inhalation Revenue by Region (2021-2026)
6.2 APAC Powder for Inhalation Sales by Type (2021-2026)
6.3 APAC Powder for Inhalation Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Powder for Inhalation by Country
7.1.1 Europe Powder for Inhalation Sales by Country (2021-2026)
7.1.2 Europe Powder for Inhalation Revenue by Country (2021-2026)
7.2 Europe Powder for Inhalation Sales by Type (2021-2026)
7.3 Europe Powder for Inhalation Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Powder for Inhalation by Country
8.1.1 Middle East & Africa Powder for Inhalation Sales by Country (2021-2026)
8.1.2 Middle East & Africa Powder for Inhalation Revenue by Country (2021-2026)
8.2 Middle East & Africa Powder for Inhalation Sales by Type (2021-2026)
8.3 Middle East & Africa Powder for Inhalation Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Powder for Inhalation
10.3 Manufacturing Process Analysis of Powder for Inhalation
10.4 Industry Chain Structure of Powder for Inhalation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Powder for Inhalation Distributors
11.3 Powder for Inhalation Customer
12 WORLD FORECAST REVIEW FOR POWDER FOR INHALATION BY GEOGRAPHIC REGION
12.1 Global Powder for Inhalation Market Size Forecast by Region
12.1.1 Global Powder for Inhalation Forecast by Region (2027-2032)
12.1.2 Global Powder for Inhalation Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Powder for Inhalation Forecast by Type (2027-2032)
12.7 Global Powder for Inhalation Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Powder for Inhalation Product Portfolios and Specifications
13.1.3 GSK Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Powder for Inhalation Product Portfolios and Specifications
13.2.3 Novartis Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Powder for Inhalation Product Portfolios and Specifications
13.3.3 AstraZeneca Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Chiesi Farmaceutici
13.4.1 Chiesi Farmaceutici Company Information
13.4.2 Chiesi Farmaceutici Powder for Inhalation Product Portfolios and Specifications
13.4.3 Chiesi Farmaceutici Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Chiesi Farmaceutici Main Business Overview
13.4.5 Chiesi Farmaceutici Latest Developments
13.5 Teva Pharmaceutical
13.5.1 Teva Pharmaceutical Company Information
13.5.2 Teva Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teva Pharmaceutical Main Business Overview
13.5.5 Teva Pharmaceutical Latest Developments
13.6 Sumitomo Pharma
13.6.1 Sumitomo Pharma Company Information
13.6.2 Sumitomo Pharma Powder for Inhalation Product Portfolios and Specifications
13.6.3 Sumitomo Pharma Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sumitomo Pharma Main Business Overview
13.6.5 Sumitomo Pharma Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Powder for Inhalation Product Portfolios and Specifications
13.7.3 Cipla Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Powder for Inhalation Product Portfolios and Specifications
13.8.3 Glenmark Pharmaceuticals Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Orion Corporation
13.9.1 Orion Corporation Company Information
13.9.2 Orion Corporation Powder for Inhalation Product Portfolios and Specifications
13.9.3 Orion Corporation Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Orion Corporation Main Business Overview
13.9.5 Orion Corporation Latest Developments
13.10 Bausch Health
13.10.1 Bausch Health Company Information
13.10.2 Bausch Health Powder for Inhalation Product Portfolios and Specifications
13.10.3 Bausch Health Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Bausch Health Main Business Overview
13.10.5 Bausch Health Latest Developments
13.11 Viatris
13.11.1 Viatris Company Information
13.11.2 Viatris Powder for Inhalation Product Portfolios and Specifications
13.11.3 Viatris Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Viatris Main Business Overview
13.11.5 Viatris Latest Developments
13.12 Zhejiang Xianjun Pharmaceutical
13.12.1 Zhejiang Xianjun Pharmaceutical Company Information
13.12.2 Zhejiang Xianjun Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
13.12.3 Zhejiang Xianjun Pharmaceutical Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zhejiang Xianjun Pharmaceutical Main Business Overview
13.12.5 Zhejiang Xianjun Pharmaceutical Latest Developments
13.13 Shanghai Pharmaceuticals
13.13.1 Shanghai Pharmaceuticals Company Information
13.13.2 Shanghai Pharmaceuticals Powder for Inhalation Product Portfolios and Specifications
13.13.3 Shanghai Pharmaceuticals Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Pharmaceuticals Main Business Overview
13.13.5 Shanghai Pharmaceuticals Latest Developments
13.14 Chia Tai Tianqing Pharmaceutical
13.14.1 Chia Tai Tianqing Pharmaceutical Company Information
13.14.2 Chia Tai Tianqing Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
13.14.3 Chia Tai Tianqing Pharmaceutical Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.14.5 Chia Tai Tianqing Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Powder for Inhalation Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Powder for Inhalation by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Powder for Inhalation by Country/Region, 2021, 2025 & 2032
2.2 Powder for Inhalation Segment by Type
2.2.1 Tiotropium Bromide
2.2.2 Salbutamol Sulfate
2.2.3 Beclomethasone Dipropionate
2.2.4 Others
2.2.5 Powder for Inhalation Sales by Type
2.2.5.1 Global Powder for Inhalation Sales Market Share by Type (2021-2026)
2.2.5.2 Global Powder for Inhalation Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Powder for Inhalation Sale Price by Type (2021-2026)
2.3 Powder for Inhalation Segment by Application
2.3.1 Asthma
2.3.2 COPD
2.3.3 Others
2.3.4 Powder for Inhalation Sales by Application
2.3.4.1 Global Powder for Inhalation Sale Market Share by Application (2021-2026)
2.3.4.2 Global Powder for Inhalation Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Powder for Inhalation Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Powder for Inhalation Breakdown Data by Company
3.1.1 Global Powder for Inhalation Annual Sales by Company (2021-2026)
3.1.2 Global Powder for Inhalation Sales Market Share by Company (2021-2026)
3.2 Global Powder for Inhalation Annual Revenue by Company (2021-2026)
3.2.1 Global Powder for Inhalation Revenue by Company (2021-2026)
3.2.2 Global Powder for Inhalation Revenue Market Share by Company (2021-2026)
3.3 Global Powder for Inhalation Sale Price by Company
3.4 Key Manufacturers Powder for Inhalation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Powder for Inhalation Product Location Distribution
3.4.2 Players Powder for Inhalation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POWDER FOR INHALATION BY GEOGRAPHIC REGION
4.1 World Historic Powder for Inhalation Market Size by Geographic Region (2021-2026)
4.1.1 Global Powder for Inhalation Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Powder for Inhalation Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Powder for Inhalation Market Size by Country/Region (2021-2026)
4.2.1 Global Powder for Inhalation Annual Sales by Country/Region (2021-2026)
4.2.2 Global Powder for Inhalation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Powder for Inhalation Sales Growth
4.4 APAC Powder for Inhalation Sales Growth
4.5 Europe Powder for Inhalation Sales Growth
4.6 Middle East & Africa Powder for Inhalation Sales Growth
5 AMERICAS
5.1 Americas Powder for Inhalation Sales by Country
5.1.1 Americas Powder for Inhalation Sales by Country (2021-2026)
5.1.2 Americas Powder for Inhalation Revenue by Country (2021-2026)
5.2 Americas Powder for Inhalation Sales by Type (2021-2026)
5.3 Americas Powder for Inhalation Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Powder for Inhalation Sales by Region
6.1.1 APAC Powder for Inhalation Sales by Region (2021-2026)
6.1.2 APAC Powder for Inhalation Revenue by Region (2021-2026)
6.2 APAC Powder for Inhalation Sales by Type (2021-2026)
6.3 APAC Powder for Inhalation Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Powder for Inhalation by Country
7.1.1 Europe Powder for Inhalation Sales by Country (2021-2026)
7.1.2 Europe Powder for Inhalation Revenue by Country (2021-2026)
7.2 Europe Powder for Inhalation Sales by Type (2021-2026)
7.3 Europe Powder for Inhalation Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Powder for Inhalation by Country
8.1.1 Middle East & Africa Powder for Inhalation Sales by Country (2021-2026)
8.1.2 Middle East & Africa Powder for Inhalation Revenue by Country (2021-2026)
8.2 Middle East & Africa Powder for Inhalation Sales by Type (2021-2026)
8.3 Middle East & Africa Powder for Inhalation Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Powder for Inhalation
10.3 Manufacturing Process Analysis of Powder for Inhalation
10.4 Industry Chain Structure of Powder for Inhalation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Powder for Inhalation Distributors
11.3 Powder for Inhalation Customer
12 WORLD FORECAST REVIEW FOR POWDER FOR INHALATION BY GEOGRAPHIC REGION
12.1 Global Powder for Inhalation Market Size Forecast by Region
12.1.1 Global Powder for Inhalation Forecast by Region (2027-2032)
12.1.2 Global Powder for Inhalation Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Powder for Inhalation Forecast by Type (2027-2032)
12.7 Global Powder for Inhalation Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Powder for Inhalation Product Portfolios and Specifications
13.1.3 GSK Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Powder for Inhalation Product Portfolios and Specifications
13.2.3 Novartis Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Powder for Inhalation Product Portfolios and Specifications
13.3.3 AstraZeneca Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Chiesi Farmaceutici
13.4.1 Chiesi Farmaceutici Company Information
13.4.2 Chiesi Farmaceutici Powder for Inhalation Product Portfolios and Specifications
13.4.3 Chiesi Farmaceutici Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Chiesi Farmaceutici Main Business Overview
13.4.5 Chiesi Farmaceutici Latest Developments
13.5 Teva Pharmaceutical
13.5.1 Teva Pharmaceutical Company Information
13.5.2 Teva Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teva Pharmaceutical Main Business Overview
13.5.5 Teva Pharmaceutical Latest Developments
13.6 Sumitomo Pharma
13.6.1 Sumitomo Pharma Company Information
13.6.2 Sumitomo Pharma Powder for Inhalation Product Portfolios and Specifications
13.6.3 Sumitomo Pharma Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sumitomo Pharma Main Business Overview
13.6.5 Sumitomo Pharma Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Powder for Inhalation Product Portfolios and Specifications
13.7.3 Cipla Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Powder for Inhalation Product Portfolios and Specifications
13.8.3 Glenmark Pharmaceuticals Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Orion Corporation
13.9.1 Orion Corporation Company Information
13.9.2 Orion Corporation Powder for Inhalation Product Portfolios and Specifications
13.9.3 Orion Corporation Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Orion Corporation Main Business Overview
13.9.5 Orion Corporation Latest Developments
13.10 Bausch Health
13.10.1 Bausch Health Company Information
13.10.2 Bausch Health Powder for Inhalation Product Portfolios and Specifications
13.10.3 Bausch Health Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Bausch Health Main Business Overview
13.10.5 Bausch Health Latest Developments
13.11 Viatris
13.11.1 Viatris Company Information
13.11.2 Viatris Powder for Inhalation Product Portfolios and Specifications
13.11.3 Viatris Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Viatris Main Business Overview
13.11.5 Viatris Latest Developments
13.12 Zhejiang Xianjun Pharmaceutical
13.12.1 Zhejiang Xianjun Pharmaceutical Company Information
13.12.2 Zhejiang Xianjun Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
13.12.3 Zhejiang Xianjun Pharmaceutical Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zhejiang Xianjun Pharmaceutical Main Business Overview
13.12.5 Zhejiang Xianjun Pharmaceutical Latest Developments
13.13 Shanghai Pharmaceuticals
13.13.1 Shanghai Pharmaceuticals Company Information
13.13.2 Shanghai Pharmaceuticals Powder for Inhalation Product Portfolios and Specifications
13.13.3 Shanghai Pharmaceuticals Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Pharmaceuticals Main Business Overview
13.13.5 Shanghai Pharmaceuticals Latest Developments
13.14 Chia Tai Tianqing Pharmaceutical
13.14.1 Chia Tai Tianqing Pharmaceutical Company Information
13.14.2 Chia Tai Tianqing Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
13.14.3 Chia Tai Tianqing Pharmaceutical Powder for Inhalation Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.14.5 Chia Tai Tianqing Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Powder for Inhalation Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Powder for Inhalation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Tiotropium Bromide
Table 4. Major Players of Salbutamol Sulfate
Table 5. Major Players of Beclomethasone Dipropionate
Table 6. Major Players of Others
Table 7. Global Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 8. Global Powder for Inhalation Sales Market Share by Type (2021-2026)
Table 9. Global Powder for Inhalation Revenue by Type (2021-2026) & ($ million)
Table 10. Global Powder for Inhalation Revenue Market Share by Type (2021-2026)
Table 11. Global Powder for Inhalation Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Powder for Inhalation Sale by Application (2021-2026) & (K Units)
Table 13. Global Powder for Inhalation Sale Market Share by Application (2021-2026)
Table 14. Global Powder for Inhalation Revenue by Application (2021-2026) & ($ million)
Table 15. Global Powder for Inhalation Revenue Market Share by Application (2021-2026)
Table 16. Global Powder for Inhalation Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Powder for Inhalation Sales by Company (2021-2026) & (K Units)
Table 18. Global Powder for Inhalation Sales Market Share by Company (2021-2026)
Table 19. Global Powder for Inhalation Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Powder for Inhalation Revenue Market Share by Company (2021-2026)
Table 21. Global Powder for Inhalation Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Powder for Inhalation Producing Area Distribution and Sales Area
Table 23. Players Powder for Inhalation Products Offered
Table 24. Powder for Inhalation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Powder for Inhalation Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Powder for Inhalation Sales Market Share Geographic Region (2021-2026)
Table 29. Global Powder for Inhalation Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Powder for Inhalation Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Powder for Inhalation Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Powder for Inhalation Sales Market Share by Country/Region (2021-2026)
Table 33. Global Powder for Inhalation Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Powder for Inhalation Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Powder for Inhalation Sales by Country (2021-2026) & (K Units)
Table 36. Americas Powder for Inhalation Sales Market Share by Country (2021-2026)
Table 37. Americas Powder for Inhalation Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 39. Americas Powder for Inhalation Sales by Application (2021-2026) & (K Units)
Table 40. APAC Powder for Inhalation Sales by Region (2021-2026) & (K Units)
Table 41. APAC Powder for Inhalation Sales Market Share by Region (2021-2026)
Table 42. APAC Powder for Inhalation Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 44. APAC Powder for Inhalation Sales by Application (2021-2026) & (K Units)
Table 45. Europe Powder for Inhalation Sales by Country (2021-2026) & (K Units)
Table 46. Europe Powder for Inhalation Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 48. Europe Powder for Inhalation Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Powder for Inhalation Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Powder for Inhalation Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Powder for Inhalation Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Powder for Inhalation
Table 54. Key Market Challenges & Risks of Powder for Inhalation
Table 55. Key Industry Trends of Powder for Inhalation
Table 56. Powder for Inhalation Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Powder for Inhalation Distributors List
Table 59. Powder for Inhalation Customer List
Table 60. Global Powder for Inhalation Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Powder for Inhalation Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Powder for Inhalation Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Powder for Inhalation Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Powder for Inhalation Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Powder for Inhalation Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Powder for Inhalation Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Powder for Inhalation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Powder for Inhalation Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Powder for Inhalation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Powder for Inhalation Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Powder for Inhalation Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Powder for Inhalation Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Powder for Inhalation Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. GSK Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 75. GSK Powder for Inhalation Product Portfolios and Specifications
Table 76. GSK Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. GSK Main Business
Table 78. GSK Latest Developments
Table 79. Novartis Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Powder for Inhalation Product Portfolios and Specifications
Table 81. Novartis Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. AstraZeneca Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 85. AstraZeneca Powder for Inhalation Product Portfolios and Specifications
Table 86. AstraZeneca Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. Chiesi Farmaceutici Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 90. Chiesi Farmaceutici Powder for Inhalation Product Portfolios and Specifications
Table 91. Chiesi Farmaceutici Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Chiesi Farmaceutici Main Business
Table 93. Chiesi Farmaceutici Latest Developments
Table 94. Teva Pharmaceutical Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
Table 96. Teva Pharmaceutical Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Teva Pharmaceutical Main Business
Table 98. Teva Pharmaceutical Latest Developments
Table 99. Sumitomo Pharma Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 100. Sumitomo Pharma Powder for Inhalation Product Portfolios and Specifications
Table 101. Sumitomo Pharma Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Sumitomo Pharma Main Business
Table 103. Sumitomo Pharma Latest Developments
Table 104. Cipla Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 105. Cipla Powder for Inhalation Product Portfolios and Specifications
Table 106. Cipla Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Cipla Main Business
Table 108. Cipla Latest Developments
Table 109. Glenmark Pharmaceuticals Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 110. Glenmark Pharmaceuticals Powder for Inhalation Product Portfolios and Specifications
Table 111. Glenmark Pharmaceuticals Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Glenmark Pharmaceuticals Main Business
Table 113. Glenmark Pharmaceuticals Latest Developments
Table 114. Orion Corporation Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 115. Orion Corporation Powder for Inhalation Product Portfolios and Specifications
Table 116. Orion Corporation Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Orion Corporation Main Business
Table 118. Orion Corporation Latest Developments
Table 119. Bausch Health Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 120. Bausch Health Powder for Inhalation Product Portfolios and Specifications
Table 121. Bausch Health Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Bausch Health Main Business
Table 123. Bausch Health Latest Developments
Table 124. Viatris Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 125. Viatris Powder for Inhalation Product Portfolios and Specifications
Table 126. Viatris Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Viatris Main Business
Table 128. Viatris Latest Developments
Table 129. Zhejiang Xianjun Pharmaceutical Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 130. Zhejiang Xianjun Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
Table 131. Zhejiang Xianjun Pharmaceutical Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Zhejiang Xianjun Pharmaceutical Main Business
Table 133. Zhejiang Xianjun Pharmaceutical Latest Developments
Table 134. Shanghai Pharmaceuticals Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai Pharmaceuticals Powder for Inhalation Product Portfolios and Specifications
Table 136. Shanghai Pharmaceuticals Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Shanghai Pharmaceuticals Main Business
Table 138. Shanghai Pharmaceuticals Latest Developments
Table 139. Chia Tai Tianqing Pharmaceutical Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 140. Chia Tai Tianqing Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
Table 141. Chia Tai Tianqing Pharmaceutical Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Chia Tai Tianqing Pharmaceutical Main Business
Table 143. Chia Tai Tianqing Pharmaceutical Latest Developments
Table 1. Powder for Inhalation Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Powder for Inhalation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Tiotropium Bromide
Table 4. Major Players of Salbutamol Sulfate
Table 5. Major Players of Beclomethasone Dipropionate
Table 6. Major Players of Others
Table 7. Global Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 8. Global Powder for Inhalation Sales Market Share by Type (2021-2026)
Table 9. Global Powder for Inhalation Revenue by Type (2021-2026) & ($ million)
Table 10. Global Powder for Inhalation Revenue Market Share by Type (2021-2026)
Table 11. Global Powder for Inhalation Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Powder for Inhalation Sale by Application (2021-2026) & (K Units)
Table 13. Global Powder for Inhalation Sale Market Share by Application (2021-2026)
Table 14. Global Powder for Inhalation Revenue by Application (2021-2026) & ($ million)
Table 15. Global Powder for Inhalation Revenue Market Share by Application (2021-2026)
Table 16. Global Powder for Inhalation Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Powder for Inhalation Sales by Company (2021-2026) & (K Units)
Table 18. Global Powder for Inhalation Sales Market Share by Company (2021-2026)
Table 19. Global Powder for Inhalation Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Powder for Inhalation Revenue Market Share by Company (2021-2026)
Table 21. Global Powder for Inhalation Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Powder for Inhalation Producing Area Distribution and Sales Area
Table 23. Players Powder for Inhalation Products Offered
Table 24. Powder for Inhalation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Powder for Inhalation Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Powder for Inhalation Sales Market Share Geographic Region (2021-2026)
Table 29. Global Powder for Inhalation Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Powder for Inhalation Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Powder for Inhalation Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Powder for Inhalation Sales Market Share by Country/Region (2021-2026)
Table 33. Global Powder for Inhalation Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Powder for Inhalation Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Powder for Inhalation Sales by Country (2021-2026) & (K Units)
Table 36. Americas Powder for Inhalation Sales Market Share by Country (2021-2026)
Table 37. Americas Powder for Inhalation Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 39. Americas Powder for Inhalation Sales by Application (2021-2026) & (K Units)
Table 40. APAC Powder for Inhalation Sales by Region (2021-2026) & (K Units)
Table 41. APAC Powder for Inhalation Sales Market Share by Region (2021-2026)
Table 42. APAC Powder for Inhalation Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 44. APAC Powder for Inhalation Sales by Application (2021-2026) & (K Units)
Table 45. Europe Powder for Inhalation Sales by Country (2021-2026) & (K Units)
Table 46. Europe Powder for Inhalation Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 48. Europe Powder for Inhalation Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Powder for Inhalation Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Powder for Inhalation Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Powder for Inhalation Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Powder for Inhalation Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Powder for Inhalation
Table 54. Key Market Challenges & Risks of Powder for Inhalation
Table 55. Key Industry Trends of Powder for Inhalation
Table 56. Powder for Inhalation Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Powder for Inhalation Distributors List
Table 59. Powder for Inhalation Customer List
Table 60. Global Powder for Inhalation Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Powder for Inhalation Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Powder for Inhalation Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Powder for Inhalation Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Powder for Inhalation Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Powder for Inhalation Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Powder for Inhalation Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Powder for Inhalation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Powder for Inhalation Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Powder for Inhalation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Powder for Inhalation Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Powder for Inhalation Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Powder for Inhalation Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Powder for Inhalation Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. GSK Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 75. GSK Powder for Inhalation Product Portfolios and Specifications
Table 76. GSK Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. GSK Main Business
Table 78. GSK Latest Developments
Table 79. Novartis Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Powder for Inhalation Product Portfolios and Specifications
Table 81. Novartis Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. AstraZeneca Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 85. AstraZeneca Powder for Inhalation Product Portfolios and Specifications
Table 86. AstraZeneca Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. Chiesi Farmaceutici Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 90. Chiesi Farmaceutici Powder for Inhalation Product Portfolios and Specifications
Table 91. Chiesi Farmaceutici Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Chiesi Farmaceutici Main Business
Table 93. Chiesi Farmaceutici Latest Developments
Table 94. Teva Pharmaceutical Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
Table 96. Teva Pharmaceutical Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Teva Pharmaceutical Main Business
Table 98. Teva Pharmaceutical Latest Developments
Table 99. Sumitomo Pharma Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 100. Sumitomo Pharma Powder for Inhalation Product Portfolios and Specifications
Table 101. Sumitomo Pharma Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Sumitomo Pharma Main Business
Table 103. Sumitomo Pharma Latest Developments
Table 104. Cipla Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 105. Cipla Powder for Inhalation Product Portfolios and Specifications
Table 106. Cipla Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Cipla Main Business
Table 108. Cipla Latest Developments
Table 109. Glenmark Pharmaceuticals Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 110. Glenmark Pharmaceuticals Powder for Inhalation Product Portfolios and Specifications
Table 111. Glenmark Pharmaceuticals Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Glenmark Pharmaceuticals Main Business
Table 113. Glenmark Pharmaceuticals Latest Developments
Table 114. Orion Corporation Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 115. Orion Corporation Powder for Inhalation Product Portfolios and Specifications
Table 116. Orion Corporation Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Orion Corporation Main Business
Table 118. Orion Corporation Latest Developments
Table 119. Bausch Health Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 120. Bausch Health Powder for Inhalation Product Portfolios and Specifications
Table 121. Bausch Health Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Bausch Health Main Business
Table 123. Bausch Health Latest Developments
Table 124. Viatris Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 125. Viatris Powder for Inhalation Product Portfolios and Specifications
Table 126. Viatris Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Viatris Main Business
Table 128. Viatris Latest Developments
Table 129. Zhejiang Xianjun Pharmaceutical Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 130. Zhejiang Xianjun Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
Table 131. Zhejiang Xianjun Pharmaceutical Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Zhejiang Xianjun Pharmaceutical Main Business
Table 133. Zhejiang Xianjun Pharmaceutical Latest Developments
Table 134. Shanghai Pharmaceuticals Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai Pharmaceuticals Powder for Inhalation Product Portfolios and Specifications
Table 136. Shanghai Pharmaceuticals Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Shanghai Pharmaceuticals Main Business
Table 138. Shanghai Pharmaceuticals Latest Developments
Table 139. Chia Tai Tianqing Pharmaceutical Basic Information, Powder for Inhalation Manufacturing Base, Sales Area and Its Competitors
Table 140. Chia Tai Tianqing Pharmaceutical Powder for Inhalation Product Portfolios and Specifications
Table 141. Chia Tai Tianqing Pharmaceutical Powder for Inhalation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Chia Tai Tianqing Pharmaceutical Main Business
Table 143. Chia Tai Tianqing Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Powder for Inhalation
Figure 2. Powder for Inhalation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Powder for Inhalation Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Powder for Inhalation Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Powder for Inhalation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Powder for Inhalation Sales Market Share by Country/Region (2025)
Figure 10. Powder for Inhalation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Tiotropium Bromide
Figure 12. Product Picture of Salbutamol Sulfate
Figure 13. Product Picture of Beclomethasone Dipropionate
Figure 14. Product Picture of Others
Figure 15. Global Powder for Inhalation Sales Market Share by Type in 2026
Figure 16. Global Powder for Inhalation Revenue Market Share by Type (2021-2026)
Figure 17. Powder for Inhalation Consumed in Asthma
Figure 18. Global Powder for Inhalation Market: Asthma (2021-2026) & (K Units)
Figure 19. Powder for Inhalation Consumed in COPD
Figure 20. Global Powder for Inhalation Market: COPD (2021-2026) & (K Units)
Figure 21. Powder for Inhalation Consumed in Others
Figure 22. Global Powder for Inhalation Market: Others (2021-2026) & (K Units)
Figure 23. Global Powder for Inhalation Sale Market Share by Application (2025)
Figure 24. Global Powder for Inhalation Revenue Market Share by Application in 2026
Figure 25. Powder for Inhalation Sales by Company in 2026 (K Units)
Figure 26. Global Powder for Inhalation Sales Market Share by Company in 2026
Figure 27. Powder for Inhalation Revenue by Company in 2026 ($ millions)
Figure 28. Global Powder for Inhalation Revenue Market Share by Company in 2026
Figure 29. Global Powder for Inhalation Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Powder for Inhalation Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Powder for Inhalation Sales 2021-2026 (K Units)
Figure 32. Americas Powder for Inhalation Revenue 2021-2026 ($ millions)
Figure 33. APAC Powder for Inhalation Sales 2021-2026 (K Units)
Figure 34. APAC Powder for Inhalation Revenue 2021-2026 ($ millions)
Figure 35. Europe Powder for Inhalation Sales 2021-2026 (K Units)
Figure 36. Europe Powder for Inhalation Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Powder for Inhalation Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Powder for Inhalation Revenue 2021-2026 ($ millions)
Figure 39. Americas Powder for Inhalation Sales Market Share by Country in 2026
Figure 40. Americas Powder for Inhalation Revenue Market Share by Country (2021-2026)
Figure 41. Americas Powder for Inhalation Sales Market Share by Type (2021-2026)
Figure 42. Americas Powder for Inhalation Sales Market Share by Application (2021-2026)
Figure 43. United States Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Powder for Inhalation Sales Market Share by Region in 2026
Figure 48. APAC Powder for Inhalation Revenue Market Share by Region (2021-2026)
Figure 49. APAC Powder for Inhalation Sales Market Share by Type (2021-2026)
Figure 50. APAC Powder for Inhalation Sales Market Share by Application (2021-2026)
Figure 51. China Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 55. India Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Powder for Inhalation Sales Market Share by Country in 2026
Figure 59. Europe Powder for Inhalation Revenue Market Share by Country (2021-2026)
Figure 60. Europe Powder for Inhalation Sales Market Share by Type (2021-2026)
Figure 61. Europe Powder for Inhalation Sales Market Share by Application (2021-2026)
Figure 62. Germany Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 63. France Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Powder for Inhalation Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Powder for Inhalation Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Powder for Inhalation Sales Market Share by Application (2021-2026)
Figure 70. Egypt Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Powder for Inhalation in 2026
Figure 76. Manufacturing Process Analysis of Powder for Inhalation
Figure 77. Industry Chain Structure of Powder for Inhalation
Figure 78. Channels of Distribution
Figure 79. Global Powder for Inhalation Sales Market Forecast by Region (2027-2032)
Figure 80. Global Powder for Inhalation Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Powder for Inhalation Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Powder for Inhalation Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Powder for Inhalation Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Powder for Inhalation Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Powder for Inhalation
Figure 2. Powder for Inhalation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Powder for Inhalation Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Powder for Inhalation Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Powder for Inhalation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Powder for Inhalation Sales Market Share by Country/Region (2025)
Figure 10. Powder for Inhalation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Tiotropium Bromide
Figure 12. Product Picture of Salbutamol Sulfate
Figure 13. Product Picture of Beclomethasone Dipropionate
Figure 14. Product Picture of Others
Figure 15. Global Powder for Inhalation Sales Market Share by Type in 2026
Figure 16. Global Powder for Inhalation Revenue Market Share by Type (2021-2026)
Figure 17. Powder for Inhalation Consumed in Asthma
Figure 18. Global Powder for Inhalation Market: Asthma (2021-2026) & (K Units)
Figure 19. Powder for Inhalation Consumed in COPD
Figure 20. Global Powder for Inhalation Market: COPD (2021-2026) & (K Units)
Figure 21. Powder for Inhalation Consumed in Others
Figure 22. Global Powder for Inhalation Market: Others (2021-2026) & (K Units)
Figure 23. Global Powder for Inhalation Sale Market Share by Application (2025)
Figure 24. Global Powder for Inhalation Revenue Market Share by Application in 2026
Figure 25. Powder for Inhalation Sales by Company in 2026 (K Units)
Figure 26. Global Powder for Inhalation Sales Market Share by Company in 2026
Figure 27. Powder for Inhalation Revenue by Company in 2026 ($ millions)
Figure 28. Global Powder for Inhalation Revenue Market Share by Company in 2026
Figure 29. Global Powder for Inhalation Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Powder for Inhalation Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Powder for Inhalation Sales 2021-2026 (K Units)
Figure 32. Americas Powder for Inhalation Revenue 2021-2026 ($ millions)
Figure 33. APAC Powder for Inhalation Sales 2021-2026 (K Units)
Figure 34. APAC Powder for Inhalation Revenue 2021-2026 ($ millions)
Figure 35. Europe Powder for Inhalation Sales 2021-2026 (K Units)
Figure 36. Europe Powder for Inhalation Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Powder for Inhalation Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Powder for Inhalation Revenue 2021-2026 ($ millions)
Figure 39. Americas Powder for Inhalation Sales Market Share by Country in 2026
Figure 40. Americas Powder for Inhalation Revenue Market Share by Country (2021-2026)
Figure 41. Americas Powder for Inhalation Sales Market Share by Type (2021-2026)
Figure 42. Americas Powder for Inhalation Sales Market Share by Application (2021-2026)
Figure 43. United States Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Powder for Inhalation Sales Market Share by Region in 2026
Figure 48. APAC Powder for Inhalation Revenue Market Share by Region (2021-2026)
Figure 49. APAC Powder for Inhalation Sales Market Share by Type (2021-2026)
Figure 50. APAC Powder for Inhalation Sales Market Share by Application (2021-2026)
Figure 51. China Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 55. India Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Powder for Inhalation Sales Market Share by Country in 2026
Figure 59. Europe Powder for Inhalation Revenue Market Share by Country (2021-2026)
Figure 60. Europe Powder for Inhalation Sales Market Share by Type (2021-2026)
Figure 61. Europe Powder for Inhalation Sales Market Share by Application (2021-2026)
Figure 62. Germany Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 63. France Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Powder for Inhalation Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Powder for Inhalation Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Powder for Inhalation Sales Market Share by Application (2021-2026)
Figure 70. Egypt Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Powder for Inhalation Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Powder for Inhalation in 2026
Figure 76. Manufacturing Process Analysis of Powder for Inhalation
Figure 77. Industry Chain Structure of Powder for Inhalation
Figure 78. Channels of Distribution
Figure 79. Global Powder for Inhalation Sales Market Forecast by Region (2027-2032)
Figure 80. Global Powder for Inhalation Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Powder for Inhalation Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Powder for Inhalation Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Powder for Inhalation Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Powder for Inhalation Revenue Market Share Forecast by Application (2027-2032)
